Annual ROE
-17.53%
+0.83%+4.52%
December 31, 2023
Summary
- As of February 7, 2025, JANX annual return on equity is -17.53%, with the most recent change of +0.83% (+4.52%) on December 31, 2023.
- During the last 3 years, JANX annual ROE has fallen by -63.88% (-137.82%).
- JANX annual ROE is now -134.78% below its all-time high of 50.40%, reached on December 31, 2019.
Performance
JANX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-11.37%
-1.82%-19.06%
September 30, 2024
Summary
- As of February 7, 2025, JANX quarterly return on equity is -11.37%, with the most recent change of -1.82% (-19.06%) on September 30, 2024.
- Over the past year, JANX quarterly ROE has increased by +8.05% (+41.45%).
- JANX quarterly ROE is now -123.33% below its all-time high of 48.74%, reached on March 31, 2021.
Performance
JANX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
JANX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.5% | +41.5% |
| 3 y3 years | -137.8% | +0.8% |
| 5 y5 years | -134.8% | - |
JANX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +5.7% | -19.1% | +46.1% |
| 5 y | 5-year | -134.8% | +5.7% | -123.3% | +46.1% |
| alltime | all time | -134.8% | +5.7% | -123.3% | +46.1% |
Janux Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -11.37%(+19.1%) |
| Jun 2024 | - | -9.55%(-32.7%) |
| Mar 2024 | - | -14.18%(-21.0%) |
| Dec 2023 | -17.53%(-4.5%) | -17.94%(-7.6%) |
| Sep 2023 | - | -19.42%(-7.9%) |
| Jun 2023 | - | -21.08%(+4.5%) |
| Mar 2023 | - | -20.17%(+9.9%) |
| Dec 2022 | -18.36% | -18.35%(+7.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -17.02%(+14.2%) |
| Jun 2022 | - | -14.90%(-0.2%) |
| Mar 2022 | - | -14.93%(+0.2%) |
| Dec 2021 | -18.58%(-140.1%) | -14.90%(+30.0%) |
| Sep 2021 | - | -11.46%(+18.4%) |
| Jun 2021 | - | -9.68%(-119.9%) |
| Mar 2021 | - | 48.74%(+5.2%) |
| Dec 2020 | 46.35%(-8.0%) | 46.35% |
| Dec 2019 | 50.40% | - |
FAQ
- What is Janux Therapeutics annual return on equity?
- What is the all time high annual ROE for Janux Therapeutics?
- What is Janux Therapeutics annual ROE year-on-year change?
- What is Janux Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Janux Therapeutics?
- What is Janux Therapeutics quarterly ROE year-on-year change?
What is Janux Therapeutics annual return on equity?
The current annual ROE of JANX is -17.53%
What is the all time high annual ROE for Janux Therapeutics?
Janux Therapeutics all-time high annual return on equity is 50.40%
What is Janux Therapeutics annual ROE year-on-year change?
Over the past year, JANX annual return on equity has changed by +0.83% (+4.52%)
What is Janux Therapeutics quarterly return on equity?
The current quarterly ROE of JANX is -11.37%
What is the all time high quarterly ROE for Janux Therapeutics?
Janux Therapeutics all-time high quarterly return on equity is 48.74%
What is Janux Therapeutics quarterly ROE year-on-year change?
Over the past year, JANX quarterly return on equity has changed by +8.05% (+41.45%)